Evidence map›Paper›PMID 38861157›Full record

ArticleActa neuropathologica2024

Early and selective localization of tau filaments to glutamatergic subcellular domains within the human anterodorsal thalamus.

Barbara Sárkány, Csaba Dávid, Tibor Hortobágyi, Péter Gombás, Peter Somogyi, László Acsády, Tim J Viney

Abstract read
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Thalamic nuclei insights into Alzheimer's disease.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Barbara SárkányDepartment of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. barbara.sarkany@lmh.ox.ac.uk.
Csaba DávidLendület Laboratory of Thalamus Research, Institute of Experimental Medicine, Budapest, 1083, Hungary.
Tibor HortobágyiDepartment of Neurology, Faculty of Medicine, University of Debrecen, Debrecen, 4032, Hungary.
Péter GombásDepartment of Pathology, Szt. Borbála Hospital, Tatabánya, 2800, Hungary.
Peter SomogyiDepartment of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK.
László AcsádyLendület Laboratory of Thalamus Research, Institute of Experimental Medicine, Budapest, 1083, Hungary. acsady@koki.hu.
Tim J VineyDepartment of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK. tim.viney@pharm.ox.ac.uk.ORCID 0000-0001-6444-1188

Funding

Alzheimer Society 522 AS-PhD-19a-010European Union project, Artificial Intelligence National Laboratory RRF-2.3.1-21-2022-00004H2020 European Research Council FRONTHAL 742595H2020 European Research Council INHIBITHUMAN 694988John Fell Fund, University of Oxford 0007192"Lendület" Program LP2023-2/2023Medical Research Council MC_PC_19010Medical Research Council MR/R011567/1Nemzeti Kutatási, Fejlesztési és Innovaciós Alap NKFIH_SNN_132999Nuffield Benefaction for Medicine and the Wellcome Institutional Strategic Support Fund 0009985Wellcome Trust
6 · The paper itself

Abstract

Widespread cortical accumulation of misfolded pathological tau proteins (ptau) in the form of paired helical filaments is a major hallmark of Alzheimer's disease. Subcellular localization of ptau at various stages of disease progression is likely to be informative of the cellular mechanisms involving its spread. Here, we found that the density of ptau within several distinct rostral thalamic nuclei in post-mortem human tissue (n = 25 cases) increased with the disease stage, with the anterodorsal nucleus (ADn) consistently being the most affected. In the ADn, ptau-positive elements were present already in the pre-cortical (Braak 0) stage. Tau pathology preferentially affected the calretinin-expressing subpopulation of glutamatergic neurons in the ADn. At the subcellular level, we detected ptau immunoreactivity in ADn cell bodies, dendrites, and in a specialized type of presynaptic terminal that expresses vesicular glutamate transporter 2 (vGLUT2) and likely originates from the mammillary body. The ptau-containing terminals displayed signs of degeneration, including endosomal/lysosomal organelles. In contrast, corticothalamic axon terminals lacked ptau. The data demonstrate the involvement of a specific cell population in ADn at the onset of the disease. The presence of ptau in subcortical glutamatergic presynaptic terminals supports hypotheses about the transsynaptic spread of tau selectively affecting specialized axonal pathways.

Indexed as

Alzheimer Diseasetau ProteinsAgedAged, 80 and overAnterior Thalamic NucleiCalbindin 2FemaleGlutamic AcidHumansMaleMiddle AgedNeurofibrillary TanglesNeuronsPresynaptic TerminalsVesicular Glutamate Transport Protein 2CALB2 protein, humanCalbindin 2Glutamic AcidMAPT protein, humantau ProteinsVesicular Glutamate Transport Protein 2Alzheimer’s diseasePaired helical filamentsTauThalamusvGLUT2

Identifiers

PMID38861157
PMCPMC11166832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.